{"date":"2025-09-04","count":5,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4148-2025-09-04-1711-d1336z","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-09-04","time":"17:11:45","subject":"代子公司ACI公告董事會決議股利分配","clause":"第14款","fact_date":"2025-09-04","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-09-04 17:11，「代子公司ACI公告董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-09-04-1649-1cqaj4t","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-09-04","time":"16:49:01","subject":"本公司Tofacitinib之美國挑戰專利學名藥(Paragraph IV)訴訟獲原廠輝瑞Pfizer 無償撤回侵權主張","clause":"第2款","fact_date":"2025-09-04","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-09-04 16:49，「本公司Tofacitinib之美國挑戰專利學名藥(Paragraph IV)訴訟獲原廠輝瑞Pfizer 無償撤回侵權主張」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-09-04-1533-1uvgiq","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-09-04","time":"15:33:49","subject":"公告本公司股票初次上巿前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-09-04 15:33，「公告本公司股票初次上巿前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-09-04-1430-wmxcjo","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-09-04","time":"14:30:50","subject":"公告本公司研發中植物新藥GKAC，通過美國食品藥物管理局(FDA)人體臨床試驗審查(IND)，准予進行第二期人體臨床試驗","clause":"第51款","fact_date":"2025-09-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-09-04 14:30，「公告本公司研發中植物新藥GKAC，通過美國食品藥物管理局(FDA)人體臨床試驗審查(IND)，准予進行第二期人體臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-09-04-1411-17ljfzm","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-09-04","time":"14:11:26","subject":"代重要子公司中國化學製藥股份有限公司公告減資變更登記完成","clause":"第36款","fact_date":"2025-09-04","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-09-04 14:11，「代重要子公司中國化學製藥股份有限公司公告減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}